154 related articles for article (PubMed ID: 8287893)
1. 5 alpha-reductase deficiency: human and animal models.
Imperato-McGinley J
Eur Urol; 1994; 25 Suppl 1():20-3. PubMed ID: 8287893
[TBL] [Abstract][Full Text] [Related]
2. 5-Alpha reductase deficiency: a 40-year retrospective review.
Okeigwe I; Kuohung W
Curr Opin Endocrinol Diabetes Obes; 2014 Dec; 21(6):483-7. PubMed ID: 25321150
[TBL] [Abstract][Full Text] [Related]
3. [Differentiation of external genitalia and 5 alpha-reductase].
Tohda A; Matsumoto F; Shimada K; Okuyama A
Nihon Rinsho; 2004 Feb; 62(2):275-80. PubMed ID: 14968532
[TBL] [Abstract][Full Text] [Related]
4. 5 alpha-metabolism in finasteride-treated subjects and male pseudohermaphrodites with inherited 5 alpha-reductase deficiency. A review.
Imperato-McGinley J
Eur Urol; 1991; 20 Suppl 1():78-81. PubMed ID: 1722167
[TBL] [Abstract][Full Text] [Related]
5. Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism.
Andersson S; Berman DM; Jenkins EP; Russell DW
Nature; 1991 Nov; 354(6349):159-61. PubMed ID: 1944596
[TBL] [Abstract][Full Text] [Related]
6. Role of testosterone binding to the androgen receptor in male sexual differentiation of patients with 5 alpha-reductase deficiency.
Maes M; Sultan C; Zerhouni N; Rothwell SW; Migeon CJ
J Steroid Biochem; 1979 Oct; 11(4):1385-92. PubMed ID: 513759
[No Abstract] [Full Text] [Related]
7. Familial male pseudohermaphroditism due to deficiency of 5 alpha-reductase.
Savage MO; Preece MA; Jeffcoate SL; Ransley PG; Rumsby G; Mansfield MD; Williams DI
Clin Endocrinol (Oxf); 1980 Apr; 12(4):397-406. PubMed ID: 7379320
[TBL] [Abstract][Full Text] [Related]
8. The development of a male pseudohermaphroditic rat using an inhibitor of the enzyme 5 alpha-reductase.
Imperato-McGinley J; Binienda Z; Arthur A; Mininberg DT; Vaughan ED; Quimby FW
Endocrinology; 1985 Feb; 116(2):807-12. PubMed ID: 3967629
[TBL] [Abstract][Full Text] [Related]
9. Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency.
Imperato-McGinley J; Zhu YS
Mol Cell Endocrinol; 2002 Dec; 198(1-2):51-9. PubMed ID: 12573814
[TBL] [Abstract][Full Text] [Related]
10. Steroid 5 alpha-reductase 2 deficiency.
Wilson JD; Griffin JE; Russell DW
Endocr Rev; 1993 Oct; 14(5):577-93. PubMed ID: 8262007
[TBL] [Abstract][Full Text] [Related]
11. 5 alpha-reductase deficiency in humans: support to the theory that 5 alpha-reduction of testosterone is an essential step in the control of LH secretion.
Martini L; Celotti F; Serio M
J Endocrinol Invest; 1979; 2(4):463-4. PubMed ID: 536582
[No Abstract] [Full Text] [Related]
12. Different aspects of 5 alpha-reductase deficiency in male pseudohermaphroditism and hypothyroidism.
Mauvais-Jarvis P; Kuttenn F; Mowszowicz I; Wright F
Clin Endocrinol (Oxf); 1981 May; 14(5):459-69. PubMed ID: 7307277
[No Abstract] [Full Text] [Related]
13. Steroid 5α-reductase 2 deficiency.
Mendonca BB; Batista RL; Domenice S; Costa EM; Arnhold IJ; Russell DW; Wilson JD
J Steroid Biochem Mol Biol; 2016 Oct; 163():206-11. PubMed ID: 27224879
[TBL] [Abstract][Full Text] [Related]
14. High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor.
Price P; Wass JA; Griffin JE; Leshin M; Savage MO; Large DM; Bu'Lock DE; Anderson DC; Wilson JD; Besser GM
J Clin Invest; 1984 Oct; 74(4):1496-508. PubMed ID: 6480833
[TBL] [Abstract][Full Text] [Related]
15. Male pseudohermaphroditism secondary to 5 alpha-reductase deficiency--a model for the role of androgens in both the development of the male phenotype and the evolution of a male gender identity.
Imperato-McGinley J; Peterson RE; Gautier T; Sturla E
J Steroid Biochem; 1979 Jul; 11(1B):637-45. PubMed ID: 491628
[No Abstract] [Full Text] [Related]
16. Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase.
Jenkins EP; Andersson S; Imperato-McGinley J; Wilson JD; Russell DW
J Clin Invest; 1992 Jan; 89(1):293-300. PubMed ID: 1345916
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
[TBL] [Abstract][Full Text] [Related]
18. 5-alpha-Reductase deficiency causing male pseudohermaphroditism.
Greene SA; Symes E; Brook CG
Arch Dis Child; 1978 Sep; 53(9):751-3. PubMed ID: 718244
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological induction of 5 alpha-reductase deficiency in the rat: separation of testosterone-mediated and 5 alpha-dihydrotestosterone-mediated effects.
Blohm TR; Laughlin ME; Benson HD; Johnston JO; Wright CL; Schatzman GL; Weintraub PM
Endocrinology; 1986 Sep; 119(3):959-66. PubMed ID: 3732173
[TBL] [Abstract][Full Text] [Related]
20. Male pseudohermaphroditism resulting from a novel mutation in the human steroid 5 alpha-reductase type 2 gene (SRD5A2).
Anwar R; Gilbey SG; New JP; Markham AF
Mol Pathol; 1997 Feb; 50(1):51-2. PubMed ID: 9208814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
